Skip to main content
Livermore
Livermore
ZHEN

Banque Cantonale Vaudoise

SEC CIK
0001793755
Latest filing
Jul 31, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
24,065
Value
$1.31M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of CRSP by Banque Cantonale Vaudoise, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,065$1.31M0.1%+6,602+37.8%AddedHolders
Q1 202617,463$831.0K<0.1%−227−1.3%ReducedHolders
Q4 202517,690$928.0K<0.1%+127+0.7%AddedHolders
Q3 202517,563$1.14M<0.1%−747−4.1%ReducedHolders
Q2 202518,310$891.0K<0.1%−269−1.4%ReducedHolders
Q1 202518,579$632.0K<0.1%–No prior filingHolders
Q4 2024––––Not filedHolders
Q3 202417,111$804.0K<0.1%−265−1.5%ReducedHolders
Q2 202417,376$939.0K<0.1%+782+4.7%AddedHolders
Q1 202416,594$1.13M<0.1%+458+2.8%AddedHolders
Q4 202316,136$1.01M<0.1%−72−0.4%ReducedHolders
Q3 202316,208$736.0K<0.1%−158−1.0%ReducedHolders
Q2 202316,366$918.0K<0.1%+692+4.4%AddedHolders
Q1 202315,674$709.0K<0.1%−98−0.6%ReducedHolders
Q4 202215,772$641.0K<0.1%+133+0.9%AddedHolders
Q3 202215,639$1.02M0.1%−205−1.3%ReducedHolders
Q2 202215,844$963.0K<0.1%+11,615+274.7%AddedHolders
Q1 20224,229$266.0K<0.1%+786+22.8%AddedHolders
Q4 20213,443$261.0K<0.1%−623−15.3%ReducedHolders
Q3 20214,066$455.0K<0.1%−297−6.8%ReducedHolders
Q2 20214,363$706.0K<0.1%−360−7.6%ReducedHolders
Q1 20214,723$575.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.